Cargando…
Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659994/ https://www.ncbi.nlm.nih.gov/pubmed/37647600 http://dx.doi.org/10.1182/bloodadvances.2023011063 |
_version_ | 1785137666512125952 |
---|---|
author | Fillmore, Nathanael R. La, Jennifer Wu, Julie Tsu-Yu Corrigan, June K. Branch-Elliman, Westyn Monach, Paul Brophy, Mary T. Do, Nhan V. Munshi, Nikhil C. |
author_facet | Fillmore, Nathanael R. La, Jennifer Wu, Julie Tsu-Yu Corrigan, June K. Branch-Elliman, Westyn Monach, Paul Brophy, Mary T. Do, Nhan V. Munshi, Nikhil C. |
author_sort | Fillmore, Nathanael R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10659994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-106599942023-09-01 Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders Fillmore, Nathanael R. La, Jennifer Wu, Julie Tsu-Yu Corrigan, June K. Branch-Elliman, Westyn Monach, Paul Brophy, Mary T. Do, Nhan V. Munshi, Nikhil C. Blood Adv Research Letter The American Society of Hematology 2023-09-01 /pmc/articles/PMC10659994/ /pubmed/37647600 http://dx.doi.org/10.1182/bloodadvances.2023011063 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Letter Fillmore, Nathanael R. La, Jennifer Wu, Julie Tsu-Yu Corrigan, June K. Branch-Elliman, Westyn Monach, Paul Brophy, Mary T. Do, Nhan V. Munshi, Nikhil C. Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders |
title | Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders |
title_full | Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders |
title_fullStr | Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders |
title_full_unstemmed | Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders |
title_short | Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders |
title_sort | even after sars-cov-2 booster, there is increased covid-19 breakthrough infection in patients with plasma cell disorders |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659994/ https://www.ncbi.nlm.nih.gov/pubmed/37647600 http://dx.doi.org/10.1182/bloodadvances.2023011063 |
work_keys_str_mv | AT fillmorenathanaelr evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders AT lajennifer evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders AT wujulietsuyu evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders AT corriganjunek evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders AT branchellimanwestyn evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders AT monachpaul evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders AT brophymaryt evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders AT donhanv evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders AT munshinikhilc evenaftersarscov2boosterthereisincreasedcovid19breakthroughinfectioninpatientswithplasmacelldisorders |